| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
|
Murakami, Michiyasu
|
|
|
30 |
1 |
p. 27-39
|
artikel
|
| 2 |
Clinical significance of CD155 expression in surgically resected lung squamous cell carcinoma
|
Nagano, Taichi
|
|
|
30 |
1 |
p. 62-71
|
artikel
|
| 3 |
Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
|
Taoka, Rikiya
|
|
|
30 |
1 |
p. 121-122
|
artikel
|
| 4 |
Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
|
Taoka, Rikiya
|
|
|
30 |
1 |
p. 110-120
|
artikel
|
| 5 |
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
|
Kanamori, Masayuki
|
|
|
30 |
1 |
p. 51-61
|
artikel
|
| 6 |
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
|
Nakashima, Kazuhisa
|
|
|
30 |
1 |
p. 17-26
|
artikel
|
| 7 |
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions
|
Yamaguchi, Ken
|
|
|
30 |
1 |
p. 1-16
|
artikel
|
| 8 |
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113
|
Okuno, Tatsuya
|
|
|
30 |
1 |
p. 83-91
|
artikel
|
| 9 |
Is it feasible to prolong the flushing interval for totally implantable venous access devices (TIVADs)? A systematic review and meta-analysis
|
Liu, Lei
|
|
|
30 |
1 |
p. 40-50
|
artikel
|
| 10 |
Lymphadenectomy and chemotherapy are effective treatments for patients with 2023 international federation of gynecology and obstetrics stage IIC-high risk endometrial cancer in Japan
|
Tani, Yoshinori
|
|
|
30 |
1 |
p. 144-156
|
artikel
|
| 11 |
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium
|
Uchimoto, Taizo
|
|
|
30 |
1 |
p. 123-133
|
artikel
|
| 12 |
Predictive factors of immediate continence after conventional robot-assisted radical prostatectomy: a single-institution retrospective study
|
Ozawa, Yu
|
|
|
30 |
1 |
p. 134-143
|
artikel
|
| 13 |
Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysis
|
Matsumoto, Takashi
|
|
|
30 |
1 |
p. 92-98
|
artikel
|
| 14 |
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
|
Kato, Taigo
|
|
|
30 |
1 |
p. 99-109
|
artikel
|
| 15 |
Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study
|
Iwata, Hiroji
|
|
|
30 |
1 |
p. 72-82
|
artikel
|
| 16 |
Treatment selection and influencing factors for chronic lymphocytic leukemia: a physician survey in Japan
|
Yuda, Junichiro
|
|
|
30 |
1 |
p. 157-167
|
artikel
|
Tijdschrift beschrijving